Catalyst Pharmaceuticals Partners, Inc.
CPRX · Mid Cap · NYSE · Healthcare · Biotechnology
$31.49+$0.00 (+0.00%)
Market closed · opens in 1d 0hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on CPRX
Free to track. No card required. Usually ready in 10-15 minutes.
Where CPRX sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$19.05
High$32.56
Today $31.49
Stocksbrew score
71/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$31.49
Lowest
$31.5
Median target
$31.5
Highest
$32
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 32% below avg
15.69x
Price / FCF
Strong · Cash flow supports price
18.52x
EV / EBITDA
Strong · Earnings support price
10.14x
ROIC
Strong · Excellent capital returns
78.8%
ROE
Favorable · 24.5% - strong capital efficiency
24.5%
Debt / equity
Favorable · 0.00 - strong leverage
0.00x
Current ratio
Strong · Good liquidity position
7.10x
How it stacks up against its peers
CPRX against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $3.84B | 18.1 | +11.7% | 71 |
 | $10.93B | 20.8 | +19.7% | 78 |
 | $29.41B | 30.8 | +15.5% | 78 |
 | $4.30B | 12.2 | +13.5% | 78 |
 | $1.20T | 43.3 | +49.6% | 77 |